Stoke Therapeutics, Inc. STOK
26.81 USD -0.12 (-0.45%)
Regular-session close
27.40 +0.59 +2.20%
After hours · Nov 20, 4:34 PM ET
25.94 Day range 27.78
22.50 52-week range 38.35
- YTD
- -15.53%
- 1 year
- -4.01%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 184.42M | 36.55M | 8.78M | 12.40M | 0 | |
| 184.42M | 36.55M | 8.78M | 12.40M | 0 | |
| -20.59M | -101.37M | -114.77M | -104.36M | -86.06M | |
| -6.88M | -88.98M | -104.70M | -101.07M | -85.81M | |
| -0.12 | -1.65 | -2.38 | -2.60 | -2.34 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 84.22M | 128.06M | 191.44M | 114.13M | 145.46M | |
| 418.43M | 271.56M | 228.34M | 256.07M | 238.87M | |
| 65.98M | 42.53M | 68.78M | 71.22M | 21.09M | |
| 352.46M | 229.02M | 159.56M | 184.85M | 217.78M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 45.59M | -86.85M | -81.07M | -31.87M | -66.91M | |
| -186.81M | -107.47M | 105.95M | -45.88M | -76.43M | |
| 97.39M | 131.09M | 53.01M | 46.41M | 1.28M | |
| -670.00K | -203.00K | -1.62M | -3.96M | -1.20M | |
| -43.84M | -63.23M | 77.89M | -31.34M | -142.05M |
